Variant ID | 32061 |
---|---|
Entrez Gene ID | 8085 |
Gene | MLL2 (GeneCards) |
Location | hg19 12:49434710-49434710
hg38 12:49040927-49040927 |
Disease | Asymptomatic |
Method | NGS gene panel |
Mutation(HGVS format) | NC_000012.11:g.49434710 G>A (Genome Assembly: hg19) |
Exon or Intron | Exon |
---|---|
Position in protein | 2281 |
Amino acid changes in protein | S > S |
Position in cDNA | 6843 |
Changes in cDNA | C > T |
mRNA accession | NA |
mRNA length | NA |
Reference length | 133851895 |
MAF in gnomAD genome (version 2.0.1) | 0 |
---|---|
EIGEN score | 1.9211 |
CADD Raw score (version 1.3) | 0.112908 (Deleterious) |
FATHMM raw prediction score | 0.96711 (Tolerated) |
Deleterious probability by DeFine | 0.8278 (Deleterious) |
Entrez Gene ID | 8085 (NCBI Gene) |
---|---|
Official Gene Symbol | MLL2 (GeneCards) |
Number of variants in KMT2D in this database | 107 (view all the variants) |
Full name | lysine methyltransferase 2D |
Band | 12q13.12 |
Other IDs | Vega: OTTHUMG00000166524 OMIM: 602113 HGNC: HGNC:7133 Ensembl: ENSG00000167548 |
Other names | ALR, KMS, MLL2, MLL4, AAD10, KABUK1, TNRC21, CAGL114 |
Summary | The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010] |
Individual ID | 25999502.02 (view all the variants in this individual) |
---|---|
Pubmed ID | 25999502 |
Whose mosaic mutation | Normal |
Origin of mosaic mutation in patients | de novo |
Phenotype | 1 |
Disease | Asymptomatic |
OMIM ID |
Pubmed ID | 25999502 |
---|---|
Title | High burden and pervasive positive selection of somatic mutations in normal human skin |
Journal | Science |
Publication date | 2015.05 |
Disease | Asymptomatic |
Number of cases | Male cases: 1; Female cases: 3; |